Cargando…
Upregulation of Inflammatory Cytokines in Pulmonary Embolism Using Biochip-Array Profiling
The complex pathophysiology of pulmonary embolism (PE) involves hemostatic activation, inflammatory processes, cellular dysfunction, and hemodynamic derangements. Due to the heterogeneity of this disease, risk stratification and diagnosis remains challenging. Biochip-array technology provides an int...
Autores principales: | Bontekoe, Emily, Brailovsky, Yevgeniy, Hoppensteadt, Debra, Bontekoe, Jack, Siddiqui, Fakiha, Newman, Joshua, Iqbal, Omer, Reed, Trent, Fareed, Jawed, Darki, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113361/ https://www.ncbi.nlm.nih.gov/pubmed/33969714 http://dx.doi.org/10.1177/10760296211013107 |
Ejemplares similares
-
Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary Embolism
por: Darwish, Iman, et al.
Publicado: (2022) -
Fibrinolytic Status and Risk of Death After Acute Pulmonary
Embolism
por: Brailovsky, Yevgeniy, et al.
Publicado: (2023) -
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism
por: Phan, Trung, et al.
Publicado: (2020) -
Comparative Anticoagulant and Thrombin Generation Inhibitory Profile
of Heparin, Sulodexide and Its Components
por: Siddiqui, Fakiha, et al.
Publicado: (2020) -
Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)